Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. High Chemical Company, Div of National Generic Distributors
WARNING LETTER
•High Chemical Company, Div of National Generic Distributors•February 8, 2019

High Chemical Company, Div of National Generic Distributors – FDA Warning Letter, Feb 8, 2019

Record Details

The FDA issued a Warning Letter to High Chemical Company, a Division of National Generic Distributors, following an inspection from December 17, 2018, to February 8, 2019. The facility, located at 3901-A Nebraska Street, Levittown, Pennsylvania, was found to have significant deviations from current good manufacturing practice (CGMP) for active pharmaceutical ingredients (API), rendering their API adulterated.

Specifically, the company failed to perform appropriate quality control testing for Sarapin, a non-sterile botanical-derived API intended for sterile injectable finished drug products. This included a lack of testing for strength by dry weight, residual pesticide, and heavy metals on each batch prior to release. The firm also lacked data to support the two-year expiration date for Sarapin API.

Furthermore, Sarracenia Purpurea (Sarapin) Distillate was identified as a misbranded drug. Its labeling failed to bear adequate directions for use, specifically lacking the required statement "Caution: For manufacturing, processing, or repackaging," as per 21 CFR 201.122, despite being sold to compounding pharmacies for further processing.

The FDA acknowledged the firm's commitment to cease drug production by May 31, 2019. The letter requires a response within 15 working days detailing corrective actions, a comprehensive assessment and CAPA plan for the stability program, and clarification on

Company
High Chemical Company, Div of National Generic Distributors
Inspection date
February 8, 2019
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · bb69c795-fd65-4f1f-bb0f-ac0d79fdf0a4

Violation Codes7
21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(g)(1)(D)21 U.S.C. 352(f)(1)21 CFR 201.122

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore High Chemical Company, Div of National Generic Distributors
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.